Boxer Capital, LLC

See remarks
BOXER CAPITAL, LLC
$1,322,380,000.00
%
COMPANY
SHARES
NET TOTAL
10.15%
Mirati Therapeutics Inc
2,000,000
$134,260,000.00
6.24%
Cytokinetics Inc
2,100,000
$82,509,000.00
6.12%
BeiGene Ltd
500,000
$80,925,000.00
5.14%
Revolution Medicines Inc
3,484,264
$67,908,000.00
4.46%
Apellis Pharmaceuticals Inc
1,303,700
$58,953,000.00
3.90%
Other
25,800,714
$51,624,000.00
3.86%
Springworks Therapeutics Inc
2,075,905
$51,109,000.00
3.77%
PMV Pharmaceuticals Inc
3,498,636
$49,856,000.00
3.66%
Prometheus Biosciences Inc
1,714,000
$48,386,000.00
3.38%
Relay Therapeutics Inc
2,669,132
$44,708,000.00
3.36%
iTeos Therapeutics Inc
2,154,058
$44,374,000.00
3.25%
Merus N V
1,900,000
$43,016,000.00
3.25%
Turning Point Therapeutics I
570,745
$42,949,000.00
2.85%
Reata Pharmaceuticals Inc
1,239,000
$37,653,000.00
2.81%
SPDR SER TR
500,000
$37,135,000.00
2.74%
Arcus Biosciences Inc
1,432,200
$36,292,000.00
2.67%
Sage Therapeutics Inc
1,094,000
$35,336,000.00
2.30%
Ideaya Biosciences Inc
2,202,812
$30,399,000.00
2.24%
Bellus Health Inc New
3,200,000
$29,568,000.00
2.00%
AnaptysBio Inc
1,300,000
$26,390,000.00
1.94%
Blueprint Medicines Corp
507,374
$25,627,000.00
1.89%
Amicus Therapeutics Inc
2,325,000
$24,971,000.00
1.76%
Kinnate Biopharma Inc
1,847,559
$23,298,000.00
1.62%
Iovance Biotherapeutics Inc
1,935,133
$21,364,000.00
1.53%
Rocket Pharmaceuticals Inc
1,466,051
$20,173,000.00
1.38%
Xenon Pharmaceuticals Inc
600,000
$18,252,000.00
1.35%
Acadia Pharmaceuticals Inc
1,263,930
$17,809,000.00
1.23%
Avidity Biosciences Inc
1,121,327
$16,293,000.00
1.17%
Nurix Therapeutics Inc
1,224,892
$15,519,000.00
1.13%
Sarepta Therapeutics Inc
200,000
$14,992,000.00
1.04%
Cullinan Oncology Inc
1,074,082
$13,770,000.00
1.04%
Milestone Pharmaceuticals In
2,238,861
$13,769,000.00
0.94%
Fate Therapeutics Inc
500,000
$12,390,000.00
0.62%
Prothena Corp PLC
300,000
$8,145,000.00
0.59%
Akero Therapeutics Inc
831,495
$7,858,000.00
0.49%
Rain Therapeutics Inc
1,175,000
$6,533,000.00
0.49%
Ascendis Pharma A/S
70,000
$6,507,000.00
0.48%
NGM Biopharmaceuticals Inc
500,000
$6,410,000.00
0.41%
DBV Technologies S A
2,134,598
$5,443,000.00
0.37%
Black Diamond Therapeutics I
2,014,858
$4,957,000.00
0.37%
BCLS Acquisition Corp
500,000
$4,950,000.00